跳至主要内容
临床试验/NCT03034707
NCT03034707已完成不适用

Interference of Biotin Supplementation in Biotin-streptavidin Platforms for Hormone Testing

University of Minnesota0 个研究点目标入组 12 人开始时间: 2016年4月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
12
主要终点
Hormone measurements TSH, PTH, Total T4, free T4, total T3, free T3, prolactin

研究概览

简要总结

The B vitamin biotin is widely available as an over the counter supplement, often advertised and used to promote health of hair, skin and nails. Commercially available over the counter biotin supplements contain dose ranges up to 10 mg/day (ie 333 times higher than the recommended dietary allowance). The biotin molecule is also sometimes used as part of the lab technology to measure hormone and protein levels in the blood. It is possible that high doses of ingested biotin may interfere with accurate hormone or protein measurement using biotin related in vitro measurement systems. Such interference, if present, could lead to misdiagnosis. The study will analyze laboratory levels obtained with streptavidin-biotin assay systems while ingesting biotin in currently available high dose supplements. The data will be compared to measurements obtained prior to and one week after stopping the biotin supplement.

详细描述

Specimens will be collected by venipuncture at 3 time points, including baseline (time 0), after one week of biotin supplementation (time 1, day 7), and then one week later (time 2, day 14). The time 1 specimen will be drawn approximately 2 hours after the last ingested dose of biotin on day 7. Specimen collection will include three 10 ml red top (no gel) tubes at each timepoint.

Specimens will be separated for isolation of serum using routine methods of the clinical chemistry laboratory. Serum will be stored at -80 degrees C until batch measurements as described Measurements Biotin levels will be measured on each sample. Hormone measurements will be performed using specific commercially available streptavidin-biotin assays and using different analyzers as indicated below. Immunoassay methods, not employing biotin-streptavidin methodology, will be used for negative assay controls.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy adults

排除标准

  • Pregnancy or lactation
  • Known thyroid disease (goiter, abnormal thyroid state),
  • Thyroid hormone treatment,
  • Over the counter dietary/ nutritional supplement use currently or within the last 2 weeks (excluding standard multivitamin preparations containing no more than 100% of the daily value for biotin and calcium),
  • Anticonvulsants,
  • Night shift work, smokers, adults lacking capacity to consent for themselves

研究组 & 干预措施

Biotin arm

Experimental

biotin 10 mg/day for 7 days

干预措施: biotin (Dietary Supplement)

结局指标

主要结局

Hormone measurements TSH, PTH, Total T4, free T4, total T3, free T3, prolactin

时间窗: Change from baseline, at 7 days, at 14 days

Hormone measurements using biotinylated assay conducted in certified labratory using the standard lab ranges for each test.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验